The tools we use in research should reflect the full spectrum of genetic diversity, but they often do not. This is a gap that an international team of scientists is exploring through the lens of induced pluripotent stem cell (iPSC) lines. iPSCs are a type...
Receiving a heart transplant is a life-changing journey, and you may be wondering about your treatment options. This is why The Heart Hub is excited to introduce A Hearts Journey: A Patient & Caregiver Guide to Heart Transplant. This brand-new, interactive...
On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
After eight transformative years at the Ted Rogers Centre for Heart Research (TRCHR), Dr. Soror Sharifpoor is embarking on an exciting new chapter in her career. As the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP)...
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
The Ted Rogers Centre and its partners are committed to helping commercialize new cardiovascular innovations and technologies so they may reach the market sooner.
The ECHO program is a key part of that mission – and is open to any Canadian-based clinician, scientist, entrepreneur and/or student. Applications for the 2020-21 year closed on August 28th.
To reach teams across Canada, ECHO is now entirely virtual, beginning in 2020. We are pleased to announce a call for applications for the 2020-2021 ECHO program.
Founded in 2018, ECHO is a 12-month online training program led by veteran entrepreneurs and high-calibre consultants across a variety of sectors. Comprised of a unique combination of five complementary modules, ECHO provides innovators of cardiovascular technologies with entrepreneurship training, mentorship, and networking opportunities, and the chance to pitch for start-up funding from a $250,000 pool.
Please visit our ECHO website for more details.
ECHO is organized and funded by the Translational Biology and Engineering Program (TBEP) – the University of Toronto component of the Ted Rogers Centre for Heart Research – in partnership with the Health Innovation Hub (H2i), a University of Toronto campus-linked accelerator.
